Kelly Narine
Chief Tech/Sci/R&D Officer at CARDIOL THERAPEUTICS INC.
Profile
Kelly Narine is currently the Director of Medical Affairs at Cardiol Therapeutics, Inc. and an Independent Director at Neural Therapeutics, Inc. Previously, she worked as the Director of Clinical Affairs at Afexa Life Sciences, Inc. and as the Vice President of Research at Aurora Cannabis, Inc. She received her doctorate degree from the University of Alberta in 2008.
Kelly Narine active positions
| Companies | Position | Start |
|---|---|---|
| CARDIOL THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2020-09-30 |
Neural Therapeutics, Inc.
 Neural Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Neural Therapeutics, Inc. is an ethnobotanical drug-discovery company, which engages in the research and development of dietary supplements and psychedelic-based therapeutic medicines to treat mental ailments. It has established a supply chain in Peru to source certain specimen of mescaline-containing cacti, such as the San Pedro cactus. The company is headquartered in Toronto, Canada. | Director/Board Member | - |
Former positions of Kelly Narine
| Companies | Position | End |
|---|---|---|
Afexa Life Sciences, Inc.
 Afexa Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Afexa Life Sciences, Inc. engages in the development and commercialization of natural-based health products for disease prevention and health maintenance. Its product known as ChemBioPrint is used in the discovery and biological standardization of natural products that deliver consistent, verifiable and provable health benefits. The company was founded by Jacqueline Jie Shan on June 30, 1998 and is headquartered in Edmonton, Canada. | Chief Tech/Sci/R&D Officer | - |
| AURORA CANNABIS INC. | Corporate Officer/Principal | - |
Training of Kelly Narine
| University of Alberta | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AURORA CANNABIS INC. | Process Industries |
| CARDIOL THERAPEUTICS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Afexa Life Sciences, Inc.
Afexa Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Afexa Life Sciences, Inc. engages in the development and commercialization of natural-based health products for disease prevention and health maintenance. Its product known as ChemBioPrint is used in the discovery and biological standardization of natural products that deliver consistent, verifiable and provable health benefits. The company was founded by Jacqueline Jie Shan on June 30, 1998 and is headquartered in Edmonton, Canada. | Commercial Services |
Neural Therapeutics, Inc.
Neural Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Neural Therapeutics, Inc. is an ethnobotanical drug-discovery company, which engages in the research and development of dietary supplements and psychedelic-based therapeutic medicines to treat mental ailments. It has established a supply chain in Peru to source certain specimen of mescaline-containing cacti, such as the San Pedro cactus. The company is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Kelly Narine